Glycomics/Glycobiology Market Share

Based on geographically, the glycomics/glycobiology market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region.

North America industry is likely to hold largest revenue share by 2037, attributed to increasing investments in glycomics/glycobiology research, presence of all key players, along with the rising R&D investments in pharmaceutical companies for drug discovery. On the contrary, Asia Pacific is projected to witness modest growth during the forecast period owing to untapped market opportunities. Evolving pharmaceutical and biopharmaceutical industries have resulted in the immense growth of glycomics/glycobiology in the region. Moreover, investments by Contract Research Organizations (CROs) for the development and production of drugs and biologics are expected to drive the growth of the Asia Pacific market over the forecast period.